Skip to main content
ERNA
NASDAQ Life Sciences

Ernexa Therapeutics Hits ERNA-101 Manufacturing, IND Milestones; Q3 IND Filing Planned

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$11.69
Mkt Cap
$13.331M
52W Low
$3.183
52W High
$91.538
52W Position info
267% above low
Off High info
87% below high
Rel. Volume
Market data snapshot near publication time

ERNA has more than doubled off its 52-week low of $3.183.

Summary

Ernexa Therapeutics announced it has successfully completed key manufacturing and IND preparation milestones for its lead therapeutic candidate, ERNA-101. This includes completing process development, transitioning to GMP manufacturing, and initiating technology transfer activities. This progress follows recent breakthrough preclinical results for ERNA-101 announced on May 6th and a period of significant financial and compliance challenges for the company. Achieving these milestones is a critical step for the micro-cap biotech, positioning it for an Investigational New Drug (IND) submission in Q3 2026 and subsequent first-in-human clinical studies, which could be transformative for its valuation. The IND filing in Q3 2026 will be a key event to watch.

At the time of this announcement, ERNA was trading at $11.69 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $13.3M. The 52-week trading range was $3.18 to $91.54. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

ERNA - Latest Insights

ERNA
Nov 06, 2026, 4:50 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.88
Real-time Price: $1.96 info
Change: +$0.080 (+4%) info
Market Cap: $3.069M info
ERNA
Sep 30, 2026, 8:32 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $3.52
Real-time Price: $1.96 info
Change: -$1.56 (-44%) info
Market Cap: $3.069M info
ERNA
Sep 15, 2026, 8:42 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $3.54
Real-time Price: $1.96 info
Change: -$1.58 (-45%) info
Market Cap: $3.069M info
ERNA
Aug 06, 2026, 5:31 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $4.57
Real-time Price: $1.96 info
Change: -$2.61 (-57%) info
Market Cap: $3.069M info
ERNA
Jul 15, 2026, 7:50 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $11.04
Real-time Price: $1.96 info
Change: -$9.08 (-82%) info
Market Cap: $3.069M info